| 000 | 01558 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514192330.0 | ||
| 264 | 0 | _c20050307 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a0143-3636 | ||
| 024 | 7 |
_a10.1097/01.mnm.0000130244.14444.5e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStokkel, Marcel P M | |
| 245 | 0 | 0 |
_aSix month follow-up after 111In-DTPA-octreotide therapy in patients with progressive radioiodine non-responsive thyroid cancer: a pilot study. _h[electronic resource] |
| 260 |
_bNuclear medicine communications _cJul 2004 |
||
| 300 |
_a683-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOctreotide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPentetic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xtherapeutic use |
| 650 | 0 | 4 |
_aThyroglobulin _xblood |
| 650 | 0 | 4 |
_aThyroid Neoplasms _xblood |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aVerkooijen, Robbert B T | |
| 700 | 1 | _aBouwsma, Hanneke | |
| 700 | 1 | _aSmit, Jan W A | |
| 773 | 0 |
_tNuclear medicine communications _gvol. 25 _gno. 7 _gp. 683-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.mnm.0000130244.14444.5e _zAvailable from publisher's website |
| 999 |
_c14914006 _d14914006 |
||